Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Bio-IT World June 17, 2004 Hope Melville	Is It Safe? Think the safe harbor provision in patent law lets you use patented compounds in all preclinical-phase research? Think again.
Bio-IT World November 19, 2004 Lentini & Bent	Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
Bio-IT World November 12, 2002 Beth E. Arnold	Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield.
Bio-IT World November 2005 Khaleeli & Fernandez	Patent Prosecution and Enforcement in Pharmacogenomics Patenting the composition of an isolated nucleic acid sequence, an isolated protein, and small molecules is possible, but there are challenges claiming that they resulted from pharmacogenomic research.
InternetNews May 20, 2005 Sean Michael Kerner	A Primer on Software Patents A closer look at software patents and at their history and implications for IT.
Bio-IT World June 17, 2004 Cathryn Campbell	Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more.
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
Knowledge@Wharton	Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies?
CIO August 1, 2003 Lawrence Rosen	Patents: An Expensive Tax on the CIO Software patents cost you money. Like taxes, they skim from your profit margins, but in this case the fees go to pay for other companies' intellectual property.
Information Today September 15, 2011 George H. Pike	Congress Enacts Patent Reform Legislation In what is being described as the most substantial overhaul of U.S. patent law in nearly 60 years, Congress passed the Leahy-Smith America Invents Act, patent reform legislation that has been years in the making.
The Motley Fool June 15, 2005 Brian Gorman	Patented Drugs Fair Game in R&D The Supreme Court's ruling could be bad news for investors in small pharma and biotech.
IndustryWeek August 1, 2006	Patents: Eleven Issues To Consider... How patent savvy are you?
National Defense June 2008 Jerry Stouck	Right and Wrong Ways To Use Others' Patents By statute, the military and other government agencies have the right to use any patented invention to further valid government missions, and this right may be extended to government contractors.
Pharmaceutical Executive July 30, 2007 Jill Wechsler	Washington Report: Exclusivity vs. Patents To encourage innovation while supporting access to less costly therapies, Congress proposes an extensive data-exclusivity period that would delay Food and Drug Administration approval of a follow-on biologic application for 12 years.
CIO September 28, 2012 Kim S. Nash	Companies Race to the Patent Office to Protect Their IT Breakthroughs There's a patent gold rush under way as savvy companies seek to lock in the competitive advantage from their IT innovations. CIOs ought to seek patents for unique business methods and other inventions made possible by new technology.
Pharmaceutical Executive September 1, 2010	Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP.
Information Today May 2006 George H. Pike	Feature: BlackBerry: Lawsuit and Patent Reform Whether through the courts or before Congress, the BlackBerry experience suggests that some modification of patent law is not only likely, it's necessary.
Chemistry World March 3, 2015 Rebecca Trager	US universities warn against patent reform proposals Legislation pending in the US Congress to address so-called patent trolling is crafted too broadly and would damage the flow of discoveries from academia to the private sector.
Pharmaceutical Executive March 1, 2011	A Rule of Thumb Gets Shot Down The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process.
Salon.com April 24, 2000 Mark Compton	Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
Knowledge@Wharton	Why High-Tech Firms Can't Afford to Ignore Patents When it comes to patents, high technology firms are, out of necessity, interdependent...
The Motley Fool February 13, 2008 Stephen Albainy-Jenei	One Privileged Position Biomedical Patent Management sued the California Department of Health Services, claiming patent infringement, but the State of California can claim immunity from patent suits.
Chemistry World March 23, 2012 Rebecca Trager	Court throws out patent covering drug dosing The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented because they are based on laws of nature.
Bank Technology News January 2004 Karen Krebsbach	Bight Ideas Financial services firms are deluging the U.S. Patent and Trademark Office with applications, which soared 15-fold between 1995 and 2002. Patent attorney Dale Lazar urges banks to get in line: converting valuable ideas into assets can pay off big time.
BusinessWeek January 9, 2006 Michael Orey	The Patent Epidemic Overpatenting is wasting companies' money and slowing the development of new products.
The Motley Fool September 12, 2005 M.D. Mitchell	Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch.
The Motley Fool February 2, 2010 Brian Orelli	Shaking Up the Biotech Industry A judge will decide if genes are patentable or not.
Pharmaceutical Executive October 1, 2014 David Dalke	New Patent-Defense Path for Pharma Inter Partes Review can potentially offer a more economical and streamlined litigation strategy for pharma and biotech players.
InternetNews June 9, 2011	Microsoft Loses Supreme Court Patent Case Top U.S. court rules against Microsoft in i4i patent appeal.
Entrepreneur October 2005 Chris Penttila	Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law.
Chemistry World October 2006	Head to Head For: Patents protect inventions by giving the owner of the patent the right to stop anyone from making or using the invention without the owner's permission... Against: Patents are a menace...
The Motley Fool August 31, 2011 John Grgurich	How the Patent Wars Are Hurting High-Tech Well-intentioned patent laws are threatening to stifle innovation.
The Motley Fool June 1, 2007 Brian Lawler	The Generic Cracks Open for Pfizer Pfizer loses a patent case over its top compound. The larger takeaway from the Lipitor legal saga is that investors always need to be aware of the strength of a drug company's patents throughout the world.
IEEE Spectrum June 2007 Suhas Sreedhar	Peer Review Starts for Software Patent Applications Hoping to curtail the orgy of tech-industry litigation, the U.S. Patent and Trademark Office recently launched an Internet-based peer-review program whereby anyone can help to evaluate a number of software patent applications voluntarily submitted for public evaluation.
InternetNews February 16, 2007 Roy Mark	Patent Reform: Beware of Unintended Consequences Is it fair to patent software?
Pharmaceutical Executive June 1, 2005 Peter J. Pitts	Opinion: Uncle Sam, MD Is having the government pursue a patent the best way of placing important discoveries in the public domain? It depends. Is putting the government in control of drug development in the best interests of public health? No.
InternetNews April 18, 2007 Roy Mark	Dems, Republicans Unite on Patent Reform Identical bills introduced in House and Senate to reduce infringement awards and to change Patent Office procedures.
The Motley Fool March 13, 2008 Stephen Albainy-Jenei	Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex.
Chemistry World March 6, 2015 Rebecca Trager	US universities back new bill to curb patent trolls The academic research community is endorsing new legislation to clamp down on so-called patent trolling, introduced by Senator Chris Coons and several Democratic colleagues.
Bio-IT World August 13, 2003 Kevin Davies	Malcolm in the Middle A maverick scientist and entrepreneur finds himself at the center of a DNA patenting storm.
BusinessWeek May 14, 2007 Michael Orey	A Higher Hurdle For Inventors Has it become too easy to win and defend patents? The Supreme Court says yes.
IEEE Spectrum August 2005 Ben Klemens	New Legal Code Copyrights should replace software patents.
Bio-IT World November 2005 Patrick R. Scanlon	Patent Term Extension Primer U.S. patent law includes provisions for extending the patent term of medical devices and pharmaceuticals in instances when lengthy FDA approval is taking place during the term.
Wall Street & Technology September 19, 2006 Paul Allen	Patent Processing For both the patent holders and potential transgressors, technology patents can be a high-stakes game in the financial world, in both monetary awards and ongoing business feasibility.
ONLINE Nov/Dec 2008 Suzanne Sabroski	From Concept to Content: The Genesis of USGENE Last year a groundbreaking database known as USGENE was released on STN International, a service of FIZ Karlsruhe and Chemical Abstracts Service (CAS). USGENE allows searchers to perform freedom-to-operate, prior art, validity, and infringement patent sequence searches.
Bank Technology News March 2001 John Hackett	In Pursuit of Patents Bankers and their suppliers fear fallout from an over-burdened Patent and Trade Office...
InternetNews November 16, 2005 Susan Kuchinskas	PubPat Claims 'Prior Art' on JPEG Patent The Public Patent Foundation is asking the U.S. Patent office to take another look at the data compression format.